论文部分内容阅读
水产药物的研究与生产作为一门新兴产业,近几年来有了长足的发展,但药物品种混乱、疗效差、档次低等问题依然突出。市场上甚至出现了无批号、无生产许可证的产品,加之各省市执行产品质量标准不一致,使许多对鱼虾病防治无效的产品也进入市场。据不完全统计:仅国内氯制剂的生产厂家就不下四十余家,多数产品大同小异,选择使用药物仅凭厂家一面之词的宣传,导致渔民无所适从。如何规范渔药市场,把优质产品请入一个温暖的家庭?如何更好地
The research and production of aquatic drugs as a new industry has made great progress in recent years, but problems such as confusion of pharmaceutical products, poor efficacy, and low quality are still prominent. There are even products with no batch number and no production license on the market, coupled with inconsistent implementation of product quality standards by provinces and municipalities, and many products that have no effect on fish and shrimp disease prevention have also entered the market. According to incomplete statistics, only domestic manufacturers of chlorine preparations have no less than 40. Most of the products are similar, and the use of drugs only depends on the publicity of the manufacturers. This has caused fishermen to be at a loss. How to regulate the fishery medicine market and invite quality products into a warm family? How to better